These data suggest that inhibiting the fatty acid amide hydrolase (FAAH) enzyme, which metabolizes anandamide, may reduce chronic inflammation and oxidative stress in cardiovascular disease. The gene discussed is FAAH; the disease is cardiovascular disorder.